MedTrace Logo

Sodium Oxybate for Postoperative Sleep Disturbance After Thoracic Surgery

NCT07794982 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2026-08-31

No results posted yet for this study

Summary

This is a single-center, randomized, double-blind, placebo-controlled trial. Three hundred-sixty adult patients undergoing elective thoracoscopic surgery will be randomly allocated at a 1:1 ratio to receive either intraoperative sodium oxybate or placebo. The primary objective is to compare postoperative sleep quality between the two groups. Secondary outcomes include postoperative pain scores, incidence of adverse events and other peri-operative indicators.

Conditions

  • Thoracic Surgical Procedures

Interventions

DRUG

sodium oxybate

Intravenous administration during general anesthesia

DRUG

Placebo

Intravenous administration during general anesthesia

Sponsors & Collaborators

  • Jingsheng Lou

    lead OTHER

Principal Investigators

  • Jiangbei Cao, MD · Chinese PLA General Hospital

  • Weixing Zhao, MD · Chinese PLA General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07794982 on ClinicalTrials.gov